DOCSLIB.ORG

USP Dietary Supplements Reference Standards Catalog

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
USP Dietary Supplements Reference Standards Catalog Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) 1009978 N-Acetyl-D,L- F03581 F03580 (31-JAN- 1115-47-5 N/A $285.00 Methionine (100 mg) 2020) (N- Acetylmethionine) 1010022 N- F0L512 7512-17-6 N/A $215.00 Acetylglucosamine (200 mg) 1010081 N-Acetyl-L-Leucine F046G0 1188-21-2 N/A $245.00 (100 mg) (Acetyl-L- leucine) 1010106 N-Acetyl-L-Tyrosine R084G0 F0I085 (31-OCT- 537-55-3 N/A $245.00 (100 mg) 2020) 1012032 Actein (20 mg) F0H264 18642-44-9 N/A $965.00 1012101 Adenine (200 mg) R068R0 I0M090 (31-AUG- 73-24-5 N/A $220.00 2018) 1012112 S-Adenosyl-L- R089M0 R02130 (28-FEB- 979-92-0 N/A $245.00 Homocysteine (50 2019) mg) 1012134 Ademetionine F0D073 97540-22-2 N/A $670.00 Disulfate Tosylate (500 mg) (S- Adenosyl-L- Methionine Disulfate Tosylate) 1012145 Agigenin (25 mg) F 55332-76-8 N/A $625.00 1012203 Agnuside (25 mg) R081S0 F0D397 (11- 11027-63-7 N/A $1,090.00 Page 1 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) DEC-2017) 1012288 Carotenes (3 x 100 F059U0 N/A N/A $270.00 mg) 1012495 Beta Alanine (100 R033Y0 F0F111 (31-AUG- 107-95-9 N/A $275.00 mg) 2016) 1012509 L-Alanine (200 mg) R06030 H0M400 (30- 56-41-7 N/A $250.00 APR-2018) 1012517 L-Alanyl-L- F004H0 39537-23-0 N/A $245.00 Glutamine (200 mg) 1012531 L-Alanyl-L-Alanine F0M225 1948-31-8 N/A $715.00 (200 mg) 1012950 Alliin (25 mg) F2L004 F1L004 (30-NOV- 556-27-4 N/A $575.00 2016) 1013057 S-Allyl-L-cysteine F (31-OCT- N/A N/A $625.00 (25 mg) 2020) 1013727 Aloin (25 mg) (Aloin R07800 F0M265 (31- 1415-73-2 N/A $215.00 A; (S)-10-Beta-D- AUG-2018) Glucopyranosyl-1,8- dihydroxy-3- hydroxymethylanthr acen-9(10H)-one) 1019870 4- R107C0 F0M031 (31- 4271-30-1 N/A $245.00 Aminobenzoylgluta MAR-2020) mic Acid (50 mg) 1020023 Gamma- R050U0 F0L111 (31-OCT- 56-12-2 N/A $270.00 Page 2 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) Aminobutyric Acid 2020) (50 mg) 1034862 Andrographolide (50 F0I344 5508-58-7 N/A $330.00 mg) 1034873 Powdered F0I342 90244-84-1 N/A $340.00 Andrographis Extract (500 mg) 1040683 Apigenin (30 mg) R072R0 F0H245 (30-JUN- 520-36-5 N/A $295.00 (5,7-Dihydroxy-2-(4- 2018) hydroxyphenyl)-4- benzopyrone) 1040708 Apigenin-7- R080Q0 R03170 (31- 578-74-5 N/A $625.00 glucoside (30 mg) MAR-2019) 1040854 Apocarotenal (3 x 50 R10320 F0K231 (30- 1107-26-2 N/A $210.00 mg) (Beta-Apo-8'- NOV-2019) Carotenal) 1042055 Arabinose (50 mg) F02410 87-72-9 N/A $745.00 1042500 L-Arginine (200 mg) R074K0 I1J237 (30-APR- 74-79-3 N/A $290.00 2019) 1042601 Arginine R071L0 R00400 (31-JUL- 1119-34-2 N/A $235.00 Hydrochloride (125 2018) mg) 1043003 Ascorbic Acid (1 g) Y06390 R1K253 (31-JUL- 50-81-7 N/A $250.00 (Vitamin C) 2019) 1043309 Powdered F1I273 F0I273 (30-APR- 90147-43-6 N/A $215.00 Ashwagandha Root 2017) Page 3 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) Extract (1 g) 1043331 Asiaticoside (30 mg) R115M0 R04440 (31-OCT- 16830-15-2 N/A $280.00 2020) 1043819 Aspartic Acid (100 R05750 F0B087 (31-OCT- 56-84-8 N/A $250.00 mg) 2017) 1044108 Astragaloside IV R088V0 F01460 (30-NOV- 84687-43-4 N/A $215.00 (100 mg) 2020) ((3beta,6alpha,9beta ,16beta,20R,24S)- 16,25-Dihydroxy-3- (beta-D- xylopyranosyloxy)- 20,24-epoxy-9,19- cyclolanostan-6-yl beta-D- glucopyranoside) 1044119 Astragalus Root Dry F01440 N/A N/A $215.00 Extract (1 g) 1044200 Astaxanthin R070Y0 R036P0 (28-FEB- 7542-45-2 N/A $245.00 (Synthetic) (3 x 30 2019) mg) (3,3'-dihydroxy- Beta,Beta-Carotene- 4,4'-dione) 1044210 Astaxanthin Esters R034E0 (31- N/A N/A $245.00 from MAY-2021) Haematococcus Page 4 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) pluvialis (5 x 100 mg) 1045009 Atropine Sulfate R07980 R01050 (31-JUL- 5908-99-6 N/A $245.00 (500 mg) 2019) 1048233 Bacoside A3 (15 F0J420 (30-SEP- N/A N/A $480.00 mg) 2020) 1048244 Powdered Bacopa F0J416 93164-89-7 N/A $215.00 Extract (500 mg) 1048288 Beta Glucan (1 g) F0K129 9012-72-0 N/A $410.00 (Beta Glucan from Baker's Yeast (Saccharomyces cerevisiae) 1048357 Baicalein (50 mg) F106P0 491-67-8 N/A $200.00 1048368 Baicalein 7-O- F106R0 21967-41-9 N/A $200.00 Glucuronide (50 mg) 1048415 Lagerstroemia F00360 N/A N/A $215.00 speciosa Leaf Dry Extract (1g) 1065209 Berberis aristata F117F0 NA N/A $360.00 Stem Dry Extract (100 mg) 1065210 Berberine Chloride R04130 F0E185 (30-SEP- 141433-60-5 N/A $360.00 (50 mg) 2017) 1065480 Beta Carotene (7 x R096S0 G0M537 (29- 7235-40-7 N/A $245.00 Cold Shipment Page 5 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) 100 mg) (COLD FEB-2020) Required SHIPMENT REQUIRED) 1065491 Beta Carotene F0K128 N/A N/A $250.00 Cold Shipment System Suitability Required (200 mg) (COLD SHIPMENT REQUIRED) 1071268 Powdered Bilberry R091Q0 F0H286 (31- 84082-34-8 N/A $360.00 Extract (500 mg) AUG-2019) 1071381 Biochanin A (20 mg) R105N0 F0L141 (31-MAY- 491-80-5 N/A $215.00 2019) 1071508 Biotin (200 mg) R04670 J0L310 (31-JAN- 58-85-5 N/A $250.00 2018) 1075305 Bisdesmethoxycurcu R112M0 F0H152 (31- 33171-05-0 N/A $220.00 min (30 mg) OCT-2020) 1075870 Bitter Orange Fruit F092T0 N/A N/A $360.00 Flavonoids Dry Extract (1 g) 1076057 Borage Seed Oil (1 F0M139 84012-16-8 N/A $200.00 g) 1076206 Powdered Black F0D086 84776-26-1 N/A $670.00 Cohosh Extract (1.5 g) 1076250 Boswellia Serrata F0J024 N/A N/A $215.00 Extract (1 g) Page 6 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) 1076261 3-Acetyl-11-Keto- R128E0 F0J011 (31-MAR- 67416-61-9 N/A $415.00 Beta-Boswellic Acid 2021) (20 mg) 1083100 3-tert-Butyl-4- R043W0 N0L032 (31-DEC- 121-00-6 N/A $275.00 hydroxyanisole (200 2017) mg) 1085003 Caffeine (200 mg) R04330 K0K210 (30-SEP- 58-08-2 N/A $245.00 2017) 1086039 Caftaric Acid (20 F0L120 (30-NOV- 67879-58-7 N/A $590.00 mg) 2020) 1086108 Calcifediol (75 mg) R03160 G2K349 (30- 63283-36-3 N/A $715.00 NOV-2016) 1086301 Calcitriol (10 mg) R072K0 J0M085 (31-JAN- 32222-06-3 N/A $2,380.00 (COLD SHIPMENT 2019) REQUIRED) 1086356 Calcium Ascorbate R053M0 F-1 (28-FEB- 5743-28-2 N/A $245.00 (200 mg) 2018) 1086403 Calcium Carbonate R094J0 R030A0 (31-JAN- 471-34-1 N/A $245.00 (1 g) 2020) 1086425 Calcium Citrate F078M0 142606-53-9 N/A $230.00 Malate (200 mg) 1086436 Calcium Chloride (1 R113W0 F0D153 (31- 10035-04-8 N/A $250.00 g) DEC-2020) 1086800 Calcium Gluceptate R032C0 F-1 (31-MAR- 29039-00-7 N/A $245.00 (200 mg) 2017) 1086822 Calcium Gluconate F0M412 299-28-5 N/A $245.00 Page 7 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) Anhydrous (200 mg) 1086833 Calcium Gluconate F0M413 66905-23-5 N/A $250.00 Monohydrate (200 mg) (Calcium D- Gluconate Monohydrate) 1086866 Calcium (-)- R073A0 F0K014 (28-FEB- NA N/A $275.00 Hydroxycitrate (150 2019) mg) 1086888 Calcium Lactate (1 F0D227 63690-56-2 N/A $245.00 g) 1086902 Calcium G0B138 F-1 (31-JAN- 110638-68-1 N/A $230.00 Lactobionate (200 2004) mg) 1086935 Calcium Levulinate F0E142 5743-49-7 N/A $230.00 (1 g) (AS) 1087009 Calcium R10000 R029P0 (06- 137-08-6 N/A $250.00 Pantothenate (300 AUG-2018) mg) (Vitamin B5) 1087360 Calcium Succinate F037E0 159389-75-0 N/A $245.00 (200 mg) 1087406 Calcium Sulfate (1 F0D236 10101-41-4 N/A $230.00 g) (AS) 1087472 Calycosin (50 mg) F01430 20575-57-9 N/A $360.00 (7-Hydroxy-3-(3- Page 8 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) hydroxy-4- methoxyphenyl)-4H- chromen-4-one) 1087483 Calycosin 7-O-beta- F01470 20633-67-4 N/A $625.00 D-Glucopyranoside (50 mg) (3-(3- Hydroxy-4- methoxyphenyl)-4- oxo-4H-chromen7-yl beta-D- glucopyranoside) 1089149 Cannabidiol (30 mg) F138M0 13956-29-1 N/A $600.00 1089161 Cannabidiol Solution F136F0 13956-29-1 N/A $295.00 (1 mL (1mg/mL)) 1089172 Cannabinoid Acids F136E0 NA N/A $480.00 Mixture (1 mL) 1089183 Cannabinoids F136D0 NA N/A $480.00 Mixture (1 mL) 1091108 Capsaicin (100 mg) R123V0 I0L046 (30-NOV- 404-86-4 N/A $250.00 2020) 1096746 Carnosic acid (20 F011E0 3650-09-7 N/A $625.00 mg) 1096779 Casticin (25 mg) F0D358 479-91-4 N/A $1,135.00 1096790 (+)-Catechin (25 R067H0 F0H389 (28-FEB- 154-23-4 N/A $235.00 mg) 2018) Page 9 Last Updated On: May 26, 2020 USP Dietary Supplements Reference Standards Catalog Catalog # Description Current Lot Previous CAS # NDC # Unit Price Special Restriction Lot(Valid Use Date) 1096848 Powdered Cat's F0H321 289626-41-1 N/A $215.00 Claw Extract (1 g) 1105009 Powdered Chaste F0C406 91722-47-3 N/A $670.00 Tree Extract (1.5 g) 1105155 Chebulagic Acid (25 F117Y0 23094-71-5 N/A $1,070.00 mg) 1105280 Chia Seed Oil (3 x 1 F051A0 93384-40-8 N/A $190.00 g) 1105315 Chicoric Acid (20 R08480 F0L119 (30-NOV- 70831-56-0 N/A $595.00 mg) 2018) 1105417
Load more

Recommended publications
  • Opportunities and Pharmacotherapeutic Perspectives
    biomolecules Review Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives Naiara Naiana Dejani 1 , Hatem A. Elshabrawy 2 , Carlos da Silva Maia Bezerra Filho 3,4 and Damião Pergentino de Sousa 3,4,* 1 Department of Physiology and Pathology, Federal University of Paraíba, João Pessoa 58051-900, Brazil; [email protected] 2 Department of Molecular and Cellular Biology, College of Osteopathic Medicine, Sam Houston State University, Conroe, TX 77304, USA; [email protected] 3 Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Brazil; [email protected] 4 Postgraduate Program in Bioactive Natural and Synthetic Products, Federal University of Paraíba, João Pessoa 58051-900, Brazil * Correspondence: [email protected]; Tel.: +55-83-3216-7347 Abstract: In 2019, COVID-19 emerged as a severe respiratory disease that is caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The disease has been associated with high mortality rate, especially in patients with comorbidities such as diabetes, cardiovascular and kidney diseases. This could be attributed to dysregulated immune responses and severe systemic inflammation in COVID-19 patients. The use of effective antiviral drugs against SARS-CoV-2 and modulation of the immune responses could be a potential therapeutic strategy for Citation: Dejani, N.N.; Elshabrawy, COVID-19. Studies have shown that natural phenolic compounds have several pharmacological H.A.; Bezerra Filho, C.d.S.M.; properties, including anticoronavirus and immunomodulatory activities. Therefore, this review de Sousa, D.P. Anticoronavirus and discusses the dual action of these natural products from the perspective of applicability at COVID-19.
    [Show full text]
  • Schisandrin B for Treatment of Male Infertility
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.20.912147; this version posted January 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Schisandrin B for treatment of male infertility Di-Xin Zou†1,2,3, Xue-Dan Meng†1,2,3, Ying Xie1, Rui Liu1, Jia-Lun Duan1, Chun-Jie Bao1, Yi-Xuan Liu1, Ya-Fei Du1, Jia-Rui Xu1, Qian Luo1, Zhan Zhang1, Shuang Ma1, Wei-Peng Yang*3, Rui-Chao Lin*2, Wan-Liang Lu*1 1. State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, and School of Pharmaceutical Sciences, Peking University, Beijing 100191, China 2. Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China 3. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China † Both authors contributed equally to this work. Correspondence to: [email protected] Dr. Wan-Liang Lu, Ph.D. Professor School of Pharmaceutical Sciences Peking University No 38, Xueyuan Rd, Beijing 100191, China Tel & Fax: +8610 82802683 * Corresponding authors Dr. Wan-Liang Lu, [email protected] Dr. Rui-Chao Lin, [email protected] Dr. Wei-Peng Yang, [email protected] Abstract The decline of male fertility and its consequences on human populations are important public-health issues. However, there are limited choices for treatment of male infertility. In an attempt to identify a compound that could promote male fertility, we identified and characterized a library of small molecules from an ancient formulation Wuzi Yanzong-Pill, which was used as a folk medicine since the Tang dynasty of China.
    [Show full text]
  • Supplementary Materials Evodiamine Inhibits Both Stem Cell and Non-Stem
    Supplementary materials Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70 Seung Yeob Hyun, Huong Thuy Le, Hye-Young Min, Honglan Pei, Yijae Lim, Injae Song, Yen T. K. Nguyen, Suckchang Hong, Byung Woo Han, Ho-Young Lee - 1 - Table S1. Short tandem repeat (STR) DNA profiles for human cancer cell lines used in this study. MDA-MB-231 Marker H1299 H460 A549 HCT116 (MDA231) Amelogenin XX XY XY XX XX D8S1179 10, 13 12 13, 14 10, 14, 15 13 D21S11 32.2 30 29 29, 30 30, 33.2 D7S820 10 9, 12 8, 11 11, 12 8 CSF1PO 12 11, 12 10, 12 7, 10 12, 13 D3S1358 17 15, 18 16 12, 16, 17 16 TH01 6, 9.3 9.3 8, 9.3 8, 9 7, 9.3 D13S317 12 13 11 10, 12 13 D16S539 12, 13 9 11, 12 11, 13 12 D2S1338 23, 24 17, 25 24 16 21 D19S433 14 14 13 11, 12 11, 14 vWA 16, 18 17 14 17, 22 15 TPOX 8 8 8, 11 8, 9 8, 9 D18S51 16 13, 15 14, 17 15, 17 11, 16 D5S818 11 9, 10 11 10, 11 12 FGA 20 21, 23 23 18, 23 22, 23 - 2 - Table S2. Antibodies used in this study. Catalogue Target Vendor Clone Dilution ratio Application1) Number 1:1000 (WB) ADI-SPA- 1:50 (IHC) HSP70 Enzo C92F3A-5 WB, IHC, IF, IP 810-F 1:50 (IF) 1 :1000 (IP) ADI-SPA- HSP90 Enzo 9D2 1:1000 WB 840-F 1:1000 (WB) Oct4 Abcam ab19857 WB, IF 1:100 (IF) Nanog Cell Signaling 4903S D73G4 1:1000 WB Sox2 Abcam ab97959 1:1000 WB ADI-SRA- Hop Enzo DS14F5 1:1000 WB 1500-F HIF-1α BD 610958 54/HIF-1α 1:1000 WB pAkt (S473) Cell Signaling 4060S D9E 1:1000 WB Akt Cell Signaling 9272S 1:1000 WB pMEK Cell Signaling 9121S 1:1000 WB (S217/221) MEK Cell Signaling 9122S 1:1000
    [Show full text]
  • Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin
    Review Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin Rashida Ginwala, Raina Bhavsar, DeGaulle I. Chigbu, Pooja Jain and Zafar K. Khan * Department of Microbiology and Immunology, and Center for Molecular Virology and Neuroimmunology, Center for Cancer Biology, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA 19129, USA; [email protected] (R.G.); [email protected] (R.B.); [email protected] (D.I.C.); [email protected] (P.J.) * Correspondence: [email protected] Received: 28 November 2018; Accepted: 30 January 2019; Published: 5 February 2019 Abstract: Inflammation has been reported to be intimately linked to the development or worsening of several non-infectious diseases. A number of chronic conditions such as cancer, diabetes, cardiovascular disorders, autoimmune diseases, and neurodegenerative disorders emerge as a result of tissue injury and genomic changes induced by constant low-grade inflammation in and around the affected tissue or organ. The existing therapies for most of these chronic conditions sometimes leave more debilitating effects than the disease itself, warranting the advent of safer, less toxic, and more cost-effective therapeutic alternatives for the patients. For centuries, flavonoids and their preparations have been used to treat various human illnesses, and their continual use has persevered throughout the ages. This review focuses on the anti-inflammatory actions of flavonoids against chronic illnesses such as cancer, diabetes, cardiovascular diseases, and neuroinflammation with a special focus on apigenin, a relatively less toxic and non-mutagenic flavonoid with remarkable pharmacodynamics. Additionally, inflammation in the central nervous system (CNS) due to diseases such as multiple sclerosis (MS) gives ready access to circulating lymphocytes, monocytes/macrophages, and dendritic cells (DCs), causing edema, further inflammation, and demyelination.
    [Show full text]
  • Effect of Post-Harvest LED and UV Light Irradiation on the Accumulation of Flavonoids and Limonoids in the Segments of Newhall Navel Oranges
    molecules Article Effect of Post-Harvest LED and UV Light Irradiation on the Accumulation of Flavonoids and Limonoids in the Segments of Newhall Navel Oranges (Citrus sinensis Osbeck) Shengyu Liu 1, Linping Hu 1, Dong Jiang 2 and Wanpeng Xi 1,3,* 1 College of Horticulture and Landscape Architecture, Southwest University, Chongqing 400716, China; [email protected] (S.L.); [email protected] (L.H.) 2 Citrus Research Institute, Chinese Academy of Agricultural Sciences, Chongqing 400712, China; [email protected] 3 Key Laboratory of Horticulture Science for Southern Mountainous Regions, Ministry of Education, Chongqing 400715, China * Correspondence: [email protected]; Tel.: +86-23-68250483; Fax: +86-23-68251274 Received: 20 March 2019; Accepted: 4 May 2019; Published: 6 May 2019 Abstract: To investigate the effect of post-harvest light irradiation on the accumulation of flavonoids and limonoids, harvested Newhall navel oranges were continuously exposed to light-emitting diode (LED) and ultraviolet (UV) light irradiation for 6 days, and the composition and content of flavonoids and limonoids in the segments were determined using UPLC-qTOF-MS at 0, 6, and 15 days after harvest. In total, six polymethoxylated flavonoids (PMFs), five flavone-O/C-glycosides, seven flavanone-O-glycosides, and three limonoids were identified in the segments. The accumulation of these components was altered by light irradiation. Red and blue light resulted in higher levels of PMFs during exposure periods. The accumulation of PMFs was also significantly induced after white light, UVB and UVC irradiation were removed. Red and UVC irradiation induced the accumulation of flavone and flavanone glycosides throughout the entire experimental period.
    [Show full text]
  • Integrative Itraq-Based Proteomic and Transcriptomic Analysis Reveals
    Ye et al. Horticulture Research (2021) 8:157 Horticulture Research https://doi.org/10.1038/s41438-021-00591-2 www.nature.com/hortres ARTICLE Open Access Integrative iTRAQ-based proteomic and transcriptomic analysis reveals the accumulation patterns of key metabolites associated with oil quality during seed ripening of Camellia oleifera Zhouchen Ye1,JingYu1,WupingYan1,JunfengZhang1, Dongmei Yang1, Guanglong Yao1, Zijin Liu1, Yougen Wu 1 and Xilin Hou 2 Abstract Camellia oleifera (C. oleifera) is one of the four major woody oil-bearing crops in the world and has relatively high ecological, economic, and medicinal value. Its seeds undergo a series of complex physiological and biochemical changes during ripening, which is mainly manifested as the accumulation and transformation of certain metabolites closely related to oil quality, especially flavonoids and fatty acids. To obtain new insights into the underlying molecular mechanisms, a parallel analysis of the transcriptome and proteome profiles of C. oleifera seeds at different maturity levels was conducted using RNA sequencing (RNA-seq) and isobaric tags for relative and absolute quantification (iTRAQ) complemented with gas chromatography-mass spectrometry (GC-MS) data. A total of 16,530 transcripts and 1228 proteins were recognized with significant differential abundances in pairwise comparisons of samples at various developmental stages. Among these, 317 were coexpressed with a poor correlation, and most were involved in metabolic processes, including fatty acid metabolism, α-linolenic acid metabolism, and glutathione metabolism. In addition, the content of total flavonoids decreased gradually 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; with seed maturity, and the levels of fatty acids generally peaked at the fat accumulation stage; these results basically agreed with the regulation patterns of genes or proteins in the corresponding pathways.
    [Show full text]
  • Materials and Methods Metabolome Analysis Root Samples Were Collected from 2-Month Old and 2-Year Old S
    Materials and methods Metabolome analysis Root samples were collected from 2-month old and 2-year old S. baicalensis plants maintained in Shanghai Chenshan Botanical Garden, and ground into powder in liquid nitrogen then freeze dried. 20 mg of each sample was suspended in 2 ml 70% methanol and then extracted in an ultrasonic water bath for 2 h. After centrifugation at 12,000 g for 10 min, the supernatant was filtered through a 0.2 μm Millipore filter before metabolite analysis. Samples were analyzed using an UPLC-ESI-MS/MS system comprised of UPLC, Shim-pack UFLC SHIMADZU CBM30A, (www.shimadzu.com.cn/); MS, Applied Biosystems 6500 Q TRAP, (www.appliedbiosystems.com.cn/). The analytical conditions were as follows: UPLC: column, Waters ACQUITY UPLC HSS T3 C18 (1.8 µm, 2.1 mm*100 mm), the mobile phase consisted of solvent A, pure water with 0.04% acetic acid, and solvent B, acetonitrile with 0.04% acetic acid. Sample measurements were performed with a gradient program that employed the starting conditions of 95% A, 5 % B. Within 10min, a linear gradient to 5% A, 95% B was programmed, and a composition of 5% A, 95% B was kept for 1 min. Subsequently, a composition of 95% A, 5.0 % B was applied within 0.10 min and maintained for 2.9 min. The column oven was set to 40°C; the injection volume was 2 μl. Alternatively, the effluent was connected to an ESI-triple quadrupole-linear ion trap (Q TRAP)-MS. LIT and triple quadrupole (QQQ) scans were acquired on a triple quadrupole-linear ion trap mass spectrometer (Q TRAP), API 6500 Q TRAP UPLC/MS/MS System, equipped with an ESI Turbo Ion-Spray interface, operating in positive and negative ion mode and controlled by Analyst 1.6.3 software (AB Sciex).
    [Show full text]
  • Flavone and Flavonol Glycosides from the Leaves of Triumfetta Procumbens in Ryukyu Islands
    Bull. Natl. Mus. Nat. Sci., Ser. B, 38(2), pp. 63–67, May 22, 2012 Flavone and Flavonol Glycosides from the Leaves of Triumfetta procumbens in Ryukyu Islands Tsukasa Iwashina* and Goro Kokubugata Department of Botany, National Museum of Nature and Science, 4–1–1 Amakubo, Tsukuba, Ibaraki 305–0005, Japan * E-mail: [email protected] (Received 11 February 2012; accepted 28 March 2012) Abstract Four flavonoids were isolated from the leaves of Triumfetta procumbens in Ryukyu Islands for the first time. They were identified as apigenin 7-O-glucuronide, luteolin 7-O-glucuro- nide, schaftoside and kaempferol 3-O-(p-coumaroylglucoside) by UV, LC-MS, acid hydrolysis, and direct TLC and HPLC comparisons with authentic samples. From the species belonging to the family Tiliaceae sensu stricto including the genus Triumfetta, some flavonols and flavones have been found together with a few dihydroflavonols and proanthocyanidins. However, three flavonoid O-glycosides and C-glycoside except for kaempferol 3-O-(p-coumaroylglucoside), which were isolated in this experiment, were reported from the family Tiliaceae s.s. for the first time. Key words : apigenin and luteolin 7-glucuronides, flavonoids, kaempferol 3-(p-coumaroylgluco- side), schaftoside, Tiliaceae s.s., Triumfetta. 7-O-rhamnosylarabinoside and scutellarein Introduction 7-O-rhamnoside, respectively (Srinivasan and The genus Triumfetta belongs to the family Subramanian, 1981), chemical structure of trium- Tiliaceae, which was recently included in the boidin was later revised as scutellarein 6-O-β-D- family Malvaceae together with Bombacaceae xyloside-7-O-α-L-rhamnopyranoside by 1H and and Sterculiaceae by APG. The genus consists of 13C NMR and FAB-MS methods (Nair et al., ca.
    [Show full text]
  • Research Article Rapid Identification of Chemical Constituents in Artemisia Argyi Le´Vi
    Hindawi Journal of Food Quality Volume 2021, Article ID 5597327, 7 pages https://doi.org/10.1155/2021/5597327 Research Article Rapid Identification of Chemical Constituents in Artemisia argyi Le´vi. et Vant by UPLC-Q-Exactive-MS/MS Lili Cui ,1,2 Xianzhong Wang ,1,3 Jie Lu ,1 Jing Tian ,1 Li Wang ,1 Jiaojiao Qu ,1 Zhenhua Liu ,1 and Jinfeng Wei 1,4 1National R and D Center for Edible Fungus Processing Technology, Henan University, Kaifeng 475004, Henan, China 2Kaifeng Key Laboratory of Functional Components,Health Food, Henan Province, Kaifeng 475004, China 3Zhumadian Xusheng Agricultural Technology Co.,Ltd., Zhumadian 463800, China 4Minsheng College, Henan University, Kaifeng 475004, Henan, China Correspondence should be addressed to Zhenhua Liu; [email protected] and Jinfeng Wei; weijinfeng20112011@ hotmail.com Received 5 February 2021; Revised 1 April 2021; Accepted 13 April 2021; Published 21 April 2021 Academic Editor: Wei Chen Copyright © 2021 Lili Cui et al. ,is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Artemisia argyi Levi.´ et Vant is a traditional Chinese medicine with a long history, and its buds and seedlings can be used as vegetables. However, the investigations on the chemical constituents of A. argyi are not sufficient. In this paper, ultra-high performance liquid chromatography tandem hybrid quadrupole-orbitrap mass spectrometry (UPLC-Q-Exactive-MS/MS) was used to identify the chemical constituents of A. argyi. ,e Q Exactive mass spectrometer was used to collect MS and MS2 data.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0224164 A1 Lebreton (43) Pub
    US 20110224164A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0224164 A1 Lebreton (43) Pub. Date: Sep. 15, 2011 (54) FLUID COMPOSITIONS FOR IMPROVING Publication Classification SKIN CONDITIONS (51) Int. Cl. (75) Inventor: Pierre F. Lebreton, Annecy (FR) 3G 0.O :08: (73) Assignee: Allergan Industrie, SAS, Pringy (FR) (52) U.S. Cl. .......................................................... 514/54 (21)21) Appl. NoNo.: 12/777,1069 (57) ABSTRACT (22) Filed: May 10, 2010 The present specification discloses fluid compositions com O O prising a matrix polymerand stabilizing component, methods Related U.S. Application Data of making Such fluid compositions, and methods of treating (60) Provisional application No. 61/313,664, filed on Mar. skin conditions in an individual using Such fluid composi 12, 2010. tions. Patent Application Publication Sep. 15, 2011 Sheet 1 of 3 US 2011/0224164 A1 girl is" . .... i E.- &;',EE 3 isre. fire;Sigis's Patent Application Publication Sep. 15, 2011 Sheet 2 of 3 US 2011/0224164 A1 Wiscosity"in a a set g : i?vs. iii.tige: ssp. r. E. site is Patent Application Publication Sep. 15, 2011 Sheet 3 of 3 US 2011/0224164 A1 Fi; ; ; ; , ; i 3 -i-...-- m M mommam mm M. M. MS ' ' s 6. ;:S - - - is : s s: s e 3. 83 8 is is a is É . ; i: ; ------es----- .- mm M. Ma Yum YM Mm - m - -W Mmm-m a 'm m - - - S. 'm - i. So m m 3 - - - - - - - - --- f ; : : ---- ' - - - - - - - - - - - - - - - . : 2. ----------- US 2011/0224164 A1 Sep. 15, 2011 FLUID COMPOSITIONS FOR IMPROVING 0004. The fluid compositions disclosed in the present SKIN CONDITIONS specification achieve this goal.
    [Show full text]
  • Predict the Antioxidant Activity of Flavonoids
    Brazilian Journal of Pharmaceutical Sciences vol. 47, n. 2, apr./jun., 2011 Article 13C NMR spectral data and molecular descriptors to predict the antioxidant activity of flavonoids Luciana Scotti*,4 Mariane Balerine Fernandes1, Eric Muramatsu,1 Vicente de Paula Emereciano,2 Josean Fechine Tavares4, Marcelo Sobral da Silva4, Marcus Tullius Scotti3 1Faculty of Pharmaceutical Sciences, University of São Paulo, 2Institute of Chemistry, University of São Paulo, 3Center of Applied Sciences and Education, Federal University of Paraiba, 4Laboratory of Pharmaceutical Technology, LTF, University Federal of Paraíba Tissue damage due to oxidative stress is directly linked to development of many, if not all, human morbidity factors and chronic diseases. In this context, the search for dietary natural occurring molecules with antioxidant activity, such as flavonoids, has become essential. In this study, we investigated a set of 41 flavonoids (23 flavones and 18 flavonols) analyzing their structures and biological antioxidant activity. The experimental data were submitted to a QSAR (quantitative structure-activity relationships) study. NMR 13C data were used to perform a Kohonen self-organizing map study, analyzing the weight that each carbon has in the activity. Additionally, we performed MLR (multilinear regression) using GA (genetic algorithms) and molecular descriptors to analyze the role that specific carbons and substitutions play in the activity. Uniterms: Flavonoids/antioxidant activity. 13C NMR. Kohonen self-organizing map. Danos aos tecidos devido ao estresse oxidativo estão diretamente ligados ao desenvolvimento de muitos, senão todos, os fatores de sedentarismo e de doenças crônicas. Neste contexto, a busca de moléculas naturais, que participam da nossa dieta e que possuam atividade antioxidante, flavonóides, torna-se de grande interesse.
    [Show full text]
  • Inhibition of Angiotensin-Converting Enzyme Activity by Flavonoids: Structure-Activity Relationship Studies
    Inhibition of Angiotensin-Converting Enzyme Activity by Flavonoids: Structure-Activity Relationship Studies Ligia Guerrero1,2, Julia´n Castillo3, Mar Quin˜ ones1, Santiago Garcia-Vallve´ 1,4, Lluis Arola1,4, Gerard Pujadas1,4, Begon˜ a Muguerza1,4* 1 Department of Biochemistry and Biotechnology, Rovira i Virgili University, Tarragona, Spain, 2 Department of Research, Nutrition and Innovation, ALPINA S.A, Bogota´, Colombia, 3 Department of Research and Development, Nutrafur S.A., Murcia, Spain, 4 Centre Tecnolo`gic de Nutricio´ i Salut (CTNS), TECNIO, CEICS, Avinguda Universitat, Reus, Catalonia, Spain Abstract Previous studies have demonstrated that certain flavonoids can have an inhibitory effect on angiotensin-converting enzyme (ACE) activity, which plays a key role in the regulation of arterial blood pressure. In the present study, 17 flavonoids belonging to five structural subtypes were evaluated in vitro for their ability to inhibit ACE in order to establish the structural basis of their bioactivity. The ACE inhibitory (ACEI) activity of these 17 flavonoids was determined by fluorimetric method at two concentrations (500 mM and 100 mM). Their inhibitory potencies ranged from 17 to 95% at 500 mM and from 0 to 57% at 100 mM. In both cases, the highest ACEI activity was obtained for luteolin. Following the determination of ACEI activity, the flavonoids with higher ACEI activity (i.e., ACEI .60% at 500 mM) were selected for further IC50 determination. The IC50 values for luteolin, quercetin, rutin, kaempferol, rhoifolin and apigenin K were 23, 43, 64, 178, 183 and 196 mM, respectively. Our results suggest that flavonoids are an excellent source of functional antihypertensive products.
    [Show full text]